Mesalamine Dose May Lower Marker of Bowel Inflammation – IBD in the News

Edward Loftus Jr., M. D., a gastroenterologist at Mayo Clinic, discusses a recent article published in Clinical Gastroenterology and Hepatology looking at the ability of a drug driving down calprotectin, a marker of bowel inflammation, in ulcerative colitis patients.


Leave a Reply

Your email address will not be published. Required fields are marked *